Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | DEEKNISC SERVICES & SOLUTIONS PRIVATE LIMITED | 1 | ₹12,060 |
| 2 | Schedule 2 | DEEKNISC SERVICES & SOLUTIONS PRIVATE LIMITED | 1 | ₹8,880 |
| 3 | Schedule 3 | M/S NEW WAVES | 1 | ₹16,550 |
| 4 | Schedule 4 | M/S NEW WAVES | 1 | ₹11,760 |
| 5 | Schedule 5 | SMPL LIFE SCIENCES PRIVATE LIMITED | 1 | ₹11,290 |
Tender Value
₹89,251.96
EMD Value
Exempted
Closing Date
14 Jul 2025, 12:00 pmClosed
Bupivacaine 0.5 percent vial of 20 ml
Amiodarone 50 mgml ampoule of 3 ml
Amiodarone 200 mg Tablet
Amiodarone 100 mg Tablet
Adenosine 3 mg ml 2 ml Injection
7999209
GEM/2025/B/6373162
Two Packet Bid
Adenosine 3 mg ml 2 ml Injection
18 days
KANPUR CITY
Item wise evaluation
BOQ
8 documents required · 8 mandatory
1 yrs
₹31
₹1 L
80%
Exempted
14 Jul 2025
23 Jun 2025
14 Jul 2025
Drugs and Pharamceutical Products
Bupivacaine 0.5 percent vial of 20 ml
Amiodarone 50 mgml ampoule of 3 ml
Amiodarone 200 mg Tablet
Amiodarone 100 mg Tablet
Adenosine 3 mg ml 2 ml Injection
Bupivacaine 0.5% vial of 20 ml
Amiodarone 50 mg ml ampoule of 3 ml
Amiodarone 200 mg Tablet
Amiodarone 100 mg Tablet
Adenosine 3mg ml 2ml Inj
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7999209.pdf
GEM_BID
CertI_df3ab7b0-ea2c-443e-a8e41750658612470_7AFHMEDSTR.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
specification_2025-06-23-11-25-42_c2e45735a339f920ca3c05be92db0796.pdf
BOQ
boq_item_sample_2025-06-23-11-25-42_1f1983614a7c56a89f2d231afeea1d3e.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .